Desirable Services and Guidelines for the Treatment and Palliative Care of HIV Disease Patients with Cancer in Africa: A World Health Organization Consultation *

Fauci A. The AIDS Epidemic—consideration for the 21st century. N Engl J Med 1999; 341: 1046–1050.

Moore P.S. , Chang Y. Detection of herpes virus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995; 332: 1181–1185.

Thomas J.O. Acquired immunodeficiency syndrome—associated cancers in sub-Saharan Africa. Semin Oncol 2001; 28: 198–206.

Parkin D.M. , Wabing A.H. , Nambooze S. , Wabwire-Mangen F. AIDS-related cancers in Africa: maturation of the epidemic in Uganda. AIDS 1999; 13: 2563–2570.

Penn I. The changing pattern of posttransplant malignancies. Transplant Proc 1991; 23: 1101–1103.

Chokunonga E. , Levy L.M. , Bassett M.T. , Mauchaza B.G. , Thomas D.B. , Parkin D.M. Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993–1995. Int J Cancer 2000; 85: 54–59.

Borok M. , Gudza I. , Kiire C. , Levy L. , Otim-Oyet D. , Olweny C. Fulminant epidemic Kaposi's sarcoma (EKS): hallmark of AIDS in Zimbabwe [meeting abstract]. Proc Annu Meet Am Soc Clin Oncol; 1996; 15: A849.

Rothmann S. , Toorani J.M. , Andreu J.M. AIDS-associated non-Hodgkin's lymphoma. Lancet 1991; 338: 884–885.

Newton Ft , Grulich A. , Beral V. , Sindikubwabo B. , Ngilimana P.J. , Nganyira A. , Parkin D.M. Cancer and HIV infection in Rwanda. Lancet 1995; 345: 1378–1379.

Sitas F. , Bezwoda W.R. , Levin V. , Ruff P. , Kew M.C. , Hale M.J. Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa. Br J Cancer 1997; 75: 1704–1707.

Parkin D.M. , Garcia-Giannoli H. , Raphael M. , Martin A. , Katangole-Mbidde E. , Wabinga H. , Ziegler J. Non-Hodgkin lymphoma in Uganda: a case-control study. AIDS 2000; 14: 2929–2936.

Ledergerber B. , Telenti A. , Egger M. Role of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study. BMJ 1999; 319: 23–24.

Kirk O. , Pedersen C. , Cozzi-Lepri A. , Antunes F. , Miller V. , Gatell J.M. Non-Hodgkin's lymphoma in HIV infected patients in the era of highly active antiretroviral therapy. Blood 2001; 98: 3406–3412.

Newton R. A review of the aetiology of squamous cell carcinoma of the conjunctiva. Br J Cancer, 1996; 74: 1511–1513.

Chokunonga E. , Levy L.M. , Bassett M.T. , Borok M.Z. , Mauchaza B.G. , Chirenje M.Z. , Parkin D.M. AIDS and cancer in Africa: the evolving epidemic in Zimbabwe. AIDS 1999; 13: 2583–2588.

Walboomers J.M. , Jacobs M.V. , Manos M.M. , Bosch F.X. , Kummer J.A. , Shah K.V. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 39–43.

Sitas F. , Pacella-Norman R. , Carrara H. , Patel M. , Ruff P. , Sur R. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer 2000; 88: 489–492.

Olweny C.L.M. , Borok M. , Gudza I. , Clinch J. , Cheang M. , Kiire C.F. Treatment of AIDS-associated Kaposi's sarcoma in Zimbabwe: results of a randomized quality of life-focused clinical trail. [Submitted for publication 2002.]

World Health Report 2000. Health Systems: improving performance. Geneva: World Health Organization, 2000.

Human Development Report 2000. United Nations Development Programme. Carey: Oxford Press, 2000.

AIDS: Palliative Care. UNAIDS Technical Update, October 2000 [unpublished].

World Health Assembly document, A51/5. Health for All in the 21st Century. Geneva: World Health Organization [unpublished], 1998.

Essential drugs for cancer chemotherapy: memorandum from a WHO meeting. Bull World Health Organ 1985; 63: 999–1002.

Essential drugs for cancer chemotherapy. WHO consultation. Bull World Health Organ 1994; 72: 693–698.

WHO. Sikora K. , Advani S. , Koroltchouk V. , Magrath I. , Levy L. , Pinedo H. Essential drugs for cancer therapy: a World Health Organization consultation. Ann Oncol 1999; 10: 385–390.

WHO. The use of essential drugs. Ninth report of the WHO Expert Committee. WHO Technical Report Series, No. 895. Geneva: World Health Organization, 2000.

WHO. Cancer Pain Relief: a guide to opioid availability. 2nd edition. Geneva: World Health Organization, 1996.

WHO. Cancer pain relief and palliative care. Report of a WHO expert committee. WHO Technical Report Series, No. 804. Geneva: World Health Organization, 1990.

WHO. Symptom Relief in Terminal Illness. Geneva: World Health Organization, 1998.

WHO. Cancer Pain Relief and Palliative Care in Children. Geneva: World Health Organization, 1998.

WHO. Home-based long-term care. Report of a WHO study group. WHO Technical Report Series, No. 898. Geneva: World Health Organization, 2000.

Coates A. , Thomson D. , McLeod G.R. , Hersey P. , Gill P.G. , Olver I.N. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer 1993; 29A: 1731–1734.

Coates A. , Gebski V. , Signorini D. , Murray P. , McNeil D. , Byrne M. , Forbes J.F. Prognostic value of quality of life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. J Clin Oncol 1992; 10: 1833–1838.

Volm M.D. , Wenz J. Patients with advanced AIDS-related Kaposi's sarcoma (EKS) no longer require systemic therapy after introduction of effective antiretroviral therapy. [abstract] Proc Am Soc Clin Oncol 1997; 16: 46a.

Wit F.W. , Sol C.J. , Renwick N. , Roos M.T. , Pals S.T. , van Leeuwen R. Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy. AIDS 1998; 12: 218–219.

WHO. Preventive therapy against tuberculosis in people living with HIV. Wkly Epidemiol Rec 1999; 74: 385–400.

UNAIDS/WHO consultation held in Harare, Zimbabwe, 29–31 March, 2000 [unpublished]. Geneva: World Health Organization.